VERTEX PHARMACEUTICALS INC / MA of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-03-18. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Joshua S Boger | Director | Cambridge, MA |
| Eric K Brandt | Director | Cambridge, MA |
| Roger W Brimblecombe | Director | Cambridge, MA |
| Stuart JM Collinson | Director | Austin, TX |
| Eugene H Cordes | Director | Cambridge, MA |
| Matthew W Emmens | Director | Cambridge, MA |
| Bruce I Sachs | Director | Waltham, MA |
| Charles A Sanders | Director | Irving, TX |
| Elaine S Ullian | Director | Waltham, MA |
| Joshua S Boger | Executive Officer | Cambridge, MA |
| Kenneth S Boger | Executive Officer | Cambridge, MA |
| Matthew W Emmens | Executive Officer | Cambridge, MA |
| Richard C Garrison | Executive Officer | Cambridge, MA |
| Kurt C Graves | Executive Officer | Cambridge, MA |
| Lisa Kelly-Croswell | Executive Officer | Cambridge, MA |
| Freda C Lewis-Hall | Executive Officer | Cambridge, MA |
| Peter Mueller | Executive Officer | Bellevue, WA |
| Amit K Sachdev | Executive Officer | Cambridge, MA |
| Paul M Silva | Executive Officer | Cambridge, MA |
| Ian F Smith | Executive Officer | Cambridge, MA |